Hotline:
+ 49 (0) 2204 2918806
Life Sciences
Biological science comprises the whole spectrum of medical research. It includes pharmacy, health care, medical devices and diagnostics. Due to its many direct and indirect impacts, an increased focus has shifted to biotechnology during the last couple of years. Many biotech companies have developed into pharmaceutical and bio-pharmaceutical giants. The biological branch plays an important role for the majority of our society and therefore proved to be an area of particular commercial success. This also explains the strong interest in information potentially providing a strategic market advantage. This category offers diverse information on topics such as digital radiography, laboratory diagnostics, haematology, oncology etc.
Subscribe to RSS Feed

Market studies for category Life Sciences

Items 1 to 10 of 2926 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 293
  1. Net price*
    Year
  2. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    UMN Pharma Inc. (4585) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 pages
    UMN Pharma Inc. (UMN) is a biopharmaceutical company. The company develops vaccines to cure diabetes, muscular dystrophy and influenza. Its products include UMN-0502, UMN-0501, UMN-0901 and UMN-2003. UMN’s UMN-0502 is seasonal influenza vaccine. The company’s UMN-0501 and UMN-0901 are pandemic influenza vaccines. The company offers UM
    Englisch | Zukunftsanalyse | SKU: 376567
  3. €490.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Medical Dressing Market in Lebanon to 2019 - Market Size, Development, and Forecasts

    Global Research & Data Services.
    19 pages
    The industry report Medical Dressing Market in Lebanon to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for medical dressings in Lebanon. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an
    Englisch | Market Profile | SKU: 987686598
  4. $1,500.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Amunix Operating Inc. - Product Pipeline Review - 2015

    Global Markets Direct
    37 pages
    Global Markets Direct’s, ‘Amunix Operating Inc. - Product Pipeline Review - 2015’, provides an overview of the Amunix Operating Inc.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Amunix Operating Inc.’s, complete with comparativ
    Englisch | Zukunftsanalyse | SKU: 987688228
  5. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    DR. Chip Biotech Inc. (4131) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 pages
    DR. Chip Biotech Inc. (DR. Chip) is a biotechnology company. The company develops and markets biochips, image analysis devices and software, and biological reagents for medical diagnosis and research applications. Its products include laboratory accessories, food diagnostic arrays, agriculture diagnostic system, human diagnostic arrays, a
    Englisch | Zukunftsanalyse | SKU: 300532
  6. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Malignant Pleural Mesothelioma - Pipeline Review, H2 2015

    Global Markets Direct
    248 pages
    Global Markets Direct’s, ‘Malignant Pleural Mesothelioma - Pipeline Review, H2 2015’, provides an overview of the Malignant Pleural Mesothelioma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Malignant Pleural Mesothelioma, complete with comparative analysis at various stag
    Englisch | Marktstudie | SKU: 987689278
  7. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    StemCells, Inc. (STEM) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    StemCells, Inc. (StemCells) carries out research, development, and commercialization of cell-based therapeutics and related tools for use in stem cell-based drug discovery and research. Its main therapeutic product candidate, HuCNS-SC cells is in development phase for the treatment of a broad range of central nervous system disorders. Ste
    Englisch | Zukunftsanalyse | SKU: 86710
  8. $4,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Remote Patient Monitoring - Pipeline Review, 2015

    GlobalData
    112 pages
    GlobalData's Medical Devices sector report, “Remote Patient Monitoring - Pipeline Review, 2015" provides an overview of Remote Patient Monitoring currently in pipeline stage.The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report review
    Englisch | Zukunftsanalyse | SKU: 987680113
  9. $2,500.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Coronary Guidewires - Pipeline Review, 2015

    GlobalData
    68 pages
    GlobalData's Medical Devices sector report, “Coronary Guidewires - Pipeline Review, 2015" provides an overview of Coronary Guidewires currently in pipeline stage.The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major play
    Englisch | Zukunftsanalyse | SKU: 987688652
  10. $300.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Veropharm (VRPH) - Financial and Strategic SWOT Analysis Review

    GlobalData
    25 Pages
    This comprehensive SWOT profile of OAO Veropharm provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps
    Englisch | Zukunftsanalyse | SKU: 85060
  11. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Open-Angle Glaucoma - Pipeline Review, H1 2015

    Global Markets Direct
    86 pages
    Global Markets Direct’s, ‘Open-Angle Glaucoma - Pipeline Review, H1 2015’, provides an overview of the Open-Angle Glaucoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Open-Angle Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by dr
    Englisch | Zukunftsanalyse | SKU: 987678280

Items 1 to 10 of 2926 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 293